home All News open_in_new Full Article
Polpharma Biologics and Fresenius Kabi Sign Licensing Agreement for Proposed Vedolizumab Biosimilar PB016
today 1 week ago attach_file Other
attach_file
Other
attach_file
Other
attach_file
Other
attach_file
Politics
attach_file
Sport
attach_file
Other
attach_file
Other
attach_file
Economics
attach_file
Other
attach_file
Economics
attach_file
Economics
attach_file
Politics
attach_file
Other
attach_file
Other
attach_file
Economics
ID: 4120860326